CG428

Customer Review

Based on 1 Customer Validation

CG428 is a potent and selective CRBN-dependent tropomyosin receptor kinase (TRK) PROTAC degrader that has anti-tumor activity. CG428 reduces levels of the tropomyosin 3 TPM3-TRKA fusion protein in KM12 colorectal carcinoma cells (DC50 = 0.36 nM) and inhibits downstream PLCγ1 phosphorylation (IC50 = 0.33 nM). CG428 has a higher binding affinity for TRKA than TRKB and TRKC (Kd = 1 nM, 28 nM and 4.2 nM, respectively). CG428 can be used for the research of colorectal carcinoma.
(Pink: Trk Receptor ligand (HY-118271); Blue: Cereblon ligand (HY-41547); Black: linker (HY-W067489)).

For research use only. We do not sell to patients.

  • Purity: 98.18%
  • CAS No.: 2412055-93-5
  • Formula: C43H43FN10O6
  • Molecular Weight:814.86
  • Storage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs

All Trk Receptor Isoforms

More
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00